Join
Live feed
·
PRReleasevia Quantisnow
AbCellera Biologics Inc. logo

AbCellera to Report Full Year 2022 Financial Results on February 21, 2023

ByQuantisnow·Wall Street's wire, on your screen.
ABCL· AbCellera Biologics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABCL (AbCellera Biologics Inc.) and more on Quantisnow.